Location History:
- Chiba, JP (2015 - 2016)
- Kashiwa, JP (2016 - 2020)
Company Filing History:
7 out of 11 
2 out of 340 
1 out of 147 
Years Active: 2015-2020
Title: Shizue Katoh: Innovator in Medical Antibodies
Introduction
Shizue Katoh is a prominent inventor based in Kashiwa, Japan. She has made significant contributions to the field of medical research, particularly in the development of antibodies for therapeutic purposes. With a total of 7 patents to her name, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Among her latest patents, Shizue Katoh has developed an anti-human CD69 antibody, which specifically binds to human CD69 and suppresses allergic inflammation. This invention also demonstrates cross-reactivity with mouse CD69, making it a versatile tool in medical applications. Additionally, she has created an anti-ADAM28 antibody aimed at treating cancer. This antibody inhibits the enzyme activity of human ADAM28 and helps suppress the metastasis of cancer cells expressing this protein.
Career Highlights
Throughout her career, Shizue Katoh has worked with notable organizations such as Genefrontier Corporation and Keio University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community effectively.
Collaborations
Shizue has collaborated with esteemed colleagues, including Akira Miyakoshi and Kanehisa Kojoh. These partnerships have further enriched her research endeavors and expanded the scope of her innovations.
Conclusion
Shizue Katoh's work in developing innovative antibodies showcases her dedication to advancing medical science. Her contributions have the potential to lead to significant improvements in treatment options for patients.